tirzepatide contraindications pancreatitis Long-Term Side Effects: Safe Weight‑Loss Guide Who Cannot Take Tirzepatide: Safety

However, no direct head-to-head comparisons have been conducted, and the 48-week timeframe in the retatrutide trial is shorter than the 6872 week endpoints used in the semaglutide and tirzepatide phase 3 trials, making direct numerical comparison imprecise

Transitioning between tirzepatide and other GLP-1 medications Users sometimes switch between tirzepatide and semaglutide or other GLP-1 receptor agonists

How we've helped our patients feel better

They also have the ability to grow functional tissues that are able to perform certain functions in the body, from your heart to your liver

Achieve lasting weight loss and a healthier you

The FDA resolved the tirzepatide shortage in late 2024, and the discretion period that allowed broad compounding has ended (FDA shortage list update, 2024-2025)